• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
2
Screening and Behavioral Counseling Interventions to Reduce Unhealthy Alcohol Use in Adolescents and Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.筛查和行为咨询干预措施以减少青少年和成年人的不健康饮酒:美国预防服务工作组的更新证据报告和系统评价。
JAMA. 2018 Nov 13;320(18):1910-1928. doi: 10.1001/jama.2018.12086.
3
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
4
5
6
7
8
9
10

PMID:30525341
Abstract

IMPORTANCE

Unhealthy alcohol use is common and increasing in adults and is the most common cause of premature mortality in the United States.

OBJECTIVE

To systematically review the benefits and harms of screening and nonpharmacologic interventions to reduce unhealthy alcohol use to inform the U.S. Preventive Services Task Force.

DATA SOURCES

MEDLINE, PubMED, PsycINFO, and Cochrane Central Register of Controlled Trials through October 12, 2017; references of relevant publications; government Web sites; and ongoing surveillance through August 1, 2018.

STUDY SELECTION

English-language trials of benefits and harms of screening in health care settings or other comparable populations and nonpharmacologic interventions to reduce unhealthy alcohol use in screen-detected persons who report unhealthy alcohol use, and test accuracy studies of selected screening tools to detect unhealthy alcohol use.

DATA EXTRACTION AND SYNTHESIS

Two investigators independently reviewed abstracts and full-text articles, then extracted data from fair- and good-quality trials, based on predetermined criteria. Random-effects meta-analysis was used to estimate benefits of the interventions.

MAIN OUTCOMES AND MEASURES

The primary drinking outcomes were drinks per week, exceeding recommended alcohol use limits, heavy use episodes, and, for pregnant women, abstinence. Other outcomes included mortality; quality of life and consequences of alcohol use; injuries, accidents, and acute health care utilization; family, social, and academic functioning; and legal outcomes.

RESULTS

We included 113 studies (n=314,466) across all Key Questions. We did not find any studies that examined the benefits or harms of screening programs to reduce unhealthy alcohol use. For adolescents, data supported the use of the National Institute on Alcohol Abuse and Alcoholism Youth Screen and other similar one- or two-item screeners to detect alcohol use disorder. For adults, brief (1- to 3-item) screeners commonly reported sensitivity and specificity between 0.70 and 0.85, typically having better sensitivity than the full Alcohol Use Disorders Identification Test (AUDIT) for identifying the full spectrum of unhealthy use. However, the AUDIT tended to have higher specificity, particularly at the standard cutoff of 8 or higher. Evidence on the effects of interventions to reduce unhealthy alcohol use in adolescents was limited to two trials; both found mixed results for reduced alcohol use and did not report health or related outcomes. In adults, interventions reduced the number of drinks per week (weighted mean difference, −1.82 [95% confidence interval {CI}, −2.42 to −1.22]), the proportion exceeding recommended drinking limits (odds ratio [OR], 0.60 [95% CI, 0.53 to 0.67]), and the proportion reporting a heavy use episode (OR, 0.62 [95% CI, 0.55 to 0.71]), and increased the proportion of pregnant women reporting abstinence (OR, 1.92 [95% CI, 1.19 to 3.09]) after 6 to 12 months. Analyses limited to trials conducted in primary care settings and the United States suggested that effects in these most applicable trials were comparable or larger than the overall effect (e.g., for trials in primary care settings, the weighted mean difference was −2.82 [95% CI, −3.87 to −1.76]). Benefits remained through 24 months or beyond in four of seven trials with longer-term outcomes. Heterogeneity was high and effect size was associated with a number of study characteristics such as setting, target age of the population, publication year, study size, and average baseline-use levels, but not clearly associated with any intervention characteristics. Data on effectiveness in important subgroups were very limited, but analyses by sex, the most commonly reported subgroup analysis, did not indicate differences in effectiveness of the interventions. Health outcomes were sparsely reported and, with some exceptions, generally did not demonstrate group differences in effect. We found no evidence that these interventions could be harmful.

CONCLUSION

Among adults, screening instruments are available that can effectively identify persons with unhealthy alcohol use and that are feasible for use in primary care settings, and interventions in those who screen positive are associated with reductions in unhealthy alcohol use. There was no evidence that these interventions have unintended harmful effects. More evidence is needed to determine whether screening for unhealthy alcohol use is beneficial for adolescents.

摘要